Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 3Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Breast Neoplasms 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma 1Precancerous Conditions 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Hyperlipoproteinemia Type II 1Head and Neck Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colitis, Ulcerative 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Biopsy 4Polymerase Chain Reaction 3Gene Expression Profiling 3Selenium 2Mass Spectrometry 2Light Coagulation 2Immunohistochemistry 2Endoscopy 2Endoscopic Mucosal Resection 2Aspirin 2alpha-Tocopherol 1Watchful Waiting 1Vitamin E 1Sulindac 1Rosuvastatin Calcium 1Papanicolaou Test 1Methylation 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1High-Throughput Screening Assays 1Genetic Linkage 1Gastroscopes 1Esomeprazole 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1DNA Methylation 1Counseling 1Comparative Genomic Hybridization 1Cidofovir 1Chromatography, Liquid 1Chromatography, Gas 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Atorvastatin × Gastrointestinal × Clear all
NCT00335504 2017-02-15

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

National Cancer Institute (NCI)

Phase 2 Completed
85 enrolled 10 charts
GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡